title: Serum phosphorus in people with chronic kidney disease: you are what you eat.
abstract: This issue of Kidney International includes two important articles about serum phosphorus and its treatment. The article by Cannata-Andía and colleagues describes a rigorous observational study of the association between serum phosphorus level, phosphate binder use, and clinical outcomes including all-cause and cardiovascular mortality. The article by Mehrotra and colleagues addresses the association between serum phosphorus, socioeconomic status, and mortality among participants in the US-based KEEP program.
authors.affiliation: Alberta Kidney Disease Network, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Marcello
authors.initials: M
authors.lastname: Tonelli
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002614:Chelating Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D054559:Hyperphosphatemia / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000209:etiology*; D008297:Male; D010710:Phosphates / Q000097:blood*; D010758:Phosphorus / Q000097:blood*; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000628:therapy*
chemical_list: D002614:Chelating Agents; D010710:Phosphates; D010758:Phosphorus